Stereoselective metabolism of benoxaprofen in rats: Biliary excretion of benoxaprofen taurine conjugate and glucuronide

Drug Metabolism and Disposition

Volumn 26, Issue 4, 1998, Pages 332-337

  Mohri, Kiminori ^a,c   Okada, Kenji ^a   Benet, Leslie Z ^b  

^a Meiji College of Pharmacy   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENOXAPROFEN;

ANIMAL EXPERIMENT; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG METABOLISM; DRUG URINE LEVEL; ENANTIOMER; INTRAVENOUS DRUG ADMINISTRATION; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BILE; GLUCURONATES; MALE; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM;

ANIMALIA;

EID: 0031953577     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Asami M, Takasaki W, Iwabuchi H, Haruyama H, Wachi K, Terada A and Tanaka Y (1995) Stereospecific taurine conjugation of the trans-OH metabolite (active metabolite) of CS-670, a new 2-arylpropionic acid nonsteroidal anti-inflammatory drug, in dogs. Biol Pharm Bull 18:1584-1589
2. Bopp RJ, Nash JF, Ridolfo AS and Shepard ER (1979) Stereoselective inversion of (R)-(-)-benoxaprofen to the (S)-(+)-enantiomer in humans. Drug Metab Dispos 7:356-359.
3. Cashin CH, Dawson W and Kitchen EA (1977) The pharmacology of benoxaprofen (2-[4-chlorophenyl]-α-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with anti-inflammatory activity apparently unrelated to inhibition of prostaglandin synthesis. J Pharm Pharmacol 29:330-336.
4. Chatfield DH and Green JN (1978) Disposition and metabolism of benoxaprofen in laboratory animals and man. Xenobiotica 8:133-144.
5. Duthie A, Nicholls A, Freeth M, Moorhead P and Triger D (1982) Fatal cholestatic jaundice in elderly patients taking benoxaprofen. Br Med J 285:62.
6. Egger H, Bartlett F, Yuan H and Karliner J (1982) Metabolism of pirprofen in man, monkey, rat, and mouse. Drug Metab Dispos 10:529-536.
7. Furlanut M, Montanari G, Perosa A, Velussi C, Forgione A and Palatini P (1985) Absorption and disposition kinetics of flunoxaprofen and benoxaprofen in healthy volunteers. Int J Clin Pharm Res 5:165-170.
8. Goudie BM, Birnie GF, Watkinson G, MacSween RN, Kissen LH and Cunningham NE (1982) Jaundice associated with the use of benoxaprofen. Lancet 1:959.
9. Hutt AJ and Caldwell J (1983) The metabolic chiral inversion of 2-arylpropionic acids: A novel route with pharmacological consequences. J Pharm Pharmacol 35:693-704.
10. Idle JR, Millburn P and Williams RT (1978) Taurine conjugates as metabolites of arylacetic acids in the ferret. Xenobiotica 8:253-264.
11. Iwakawa S, Spahn H, Benet LZ and Lin ET (1991) Stereoselective disposition of caprofen, flunoxaprofen, and naproxen in rats. Drug Metab Dispos 19:853-857.
12. Jamali F (1988) Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs. Eur J Drug Metab Pharmacokinet 13:1-9.
13. Kitamura S, Yoshimura T, Sugihara K, Tatsumi K, Konishi T and Nishikawa H (1996) Relation between optical isomerism and taurine conjugation of phenylpropionic acid derivatives (Abstract). Xenobio Metab Dispos 11:S74-S75.
14. Mori Y, Kuroda N, Sakai Y, Yokoya F, Toyoshi K and Baba S (1985) Species differences in the metabolism of suprofen in laboratory animals and man. Drug Metab Dispos 13:239-245.
15. Nakamura Y, Yamaguchi T, Takahashi S, Hashimoto S, Iwatani K and Nakagawa Y (1981) Optical isomerization mechanism of R(-)-hydratropic acid derivatives (Abstract). J Pharmacobio-Dyn 4:S1.
16. 14C-benoxaprofen. Iyakuhin Kenkyu 12:533-546.
17. 14C-benoxaprofen in rats. Iyakuhin Kenkyu 12:516-532.
18. Sakai Y, Mori Y, Toyoshi K, Horie M and Baba S (1984) Metabolism of suprofen in the dog. Drug Metab Dispos 12:795-797.
19. Shirley MA, Guan X, Kaiser DG, Halstead GW and Baillie TA (1994) Taurine conjugation of ibuprofen in humans and in rat liver in vitro: Relationship to metabolic chiral inversion. J Pharmacol Exp Ther 269:1166-1175.
20. Simmonds RG, Woodage TJ, Duff SM and Green JN (1980) Stereospecific inversion of (R)-(-)-benoxaprofen in rat and man. Eur J Drug Metab Pharmacokinet 5:169-172.
21. Spahn H, Iwakawa S, Lin ET and Benet LZ (1989) Procedures to characterize in vivo and in vitro enantioselective glucuronidation properly: Studies with benoxaprofen glucuronides. Pharm Res 6:125-132.
22. Tanaka Y, Nishikawa Y and Hayashi R (1983) Species differences in metabolism of sodium 2-[4-(2-oxocyclopentylmethyl)phenyl]propionate dihydrate (loxoprofen sodium), a new anti-inflammatory agent. Chem Pharm Bull 31:3656-3664.
23. Tanaka Y, Shimomura Y, Hirota T, Nozaki A, Ebata M, Takasaki W, Shigehara E, Hayashi R and Caldwell J (1992) Formation of glycine conjugate and (-)-(R)-enantiomer from (+)-(S)-2-phenylpropionic acid, suggesting the formation of the CoA thioester intermediate of (+)-(S)-enantiomer in dogs. Chirality 4:342-348.
24. Tsurumi K, Kyuki K, Mibu H, Togawa Y and Fujimura H (1982) Supplement to anti-inflammatory properties of benoxaprofen. Oyo Yakuri 23:651-659.
25. Tsurumi K, Kyuki K, Nakayama T and Fujimura H (1980) Anti-inflammatory effect of benoxaprofen. Oyo Yakuri 19:555-567.